Financhill
Sell
38

QTRX Quote, Financials, Valuation and Earnings

Last price:
$6.32
Seasonality move :
-14.93%
Day range:
$5.85 - $6.24
52-week range:
$4.05 - $16.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.74x
P/B ratio:
0.74x
Volume:
569.7K
Avg. volume:
759K
1-year change:
-58.26%
Market cap:
$235.3M
Revenue:
$135.4M
EPS (TTM):
-$1.24

Analysts' Opinion

  • Consensus Rating
    Quanterix has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $11.25, Quanterix has an estimated upside of 85.64% from its current price of $6.06.
  • Price Target Downside
    According to analysts, the lowest downside price target is $7.00 representing 100% downside risk from its current price of $6.06.

Fair Value

  • According to the consensus of 3 analysts, Quanterix has 85.64% upside to fair value with a price target of $11.25 per share.

QTRX vs. S&P 500

  • Over the past 5 trading days, Quanterix has overperformed the S&P 500 by 13.29% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Quanterix does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Quanterix revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Quanterix reported revenues of $30.3M.

Earnings Growth

  • Quanterix has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Quanterix reported earnings per share of -$0.53.
Enterprise value:
-31.6M
EV / Invested capital:
-0.10x
Price / LTM sales:
1.74x
EV / EBIT:
--
EV / Revenue:
-0.24x
PEG ratio (5yr expected):
-0.11x
EV / Free cash flow:
0.96x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$79.2M
Return On Assets:
-11.75%
Net Income Margin (TTM):
-35.75%
Return On Equity:
-14.39%
Return On Invested Capital:
-14.39%
Operating Margin:
-87.09%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $103.6M $124.7M $133.9M $31.8M $30.3M
Gross Profit $46M $75.5M $79.2M $18.3M $16.4M
Operating Income -$67.1M -$49.2M -$63.8M -$15.2M -$26.4M
EBITDA -$60.9M -$40.9M -$54.8M -$13.6M -$24.2M
Diluted EPS -$2.31 -$0.85 -$1.24 -$0.29 -$0.53
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $482.4M $433.7M $376M $366.8M $335M
Total Assets $532.7M $504.7M $427.3M $411.7M $396.5M
Current Liabilities $36.5M $31.8M $26.9M $32.2M $40.4M
Total Liabilities $61.2M $78.2M $70M $70.3M $80.1M
Total Equity $471.5M $426.4M $357.3M $341.4M $316.4M
Total Debt $7.7M -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations -$36.7M -$29.2M -$28.9M -$20.2M -$13.9M
Cash From Investing -$10.4M -$257.5M $59.7M -$109.2M $32.8M
Cash From Financing $1.9M $2.7M -$50K $599K $93K
Free Cash Flow -$47.1M -$33.4M -$33M -$20.7M -$15.1M
QTRX
Sector
Market Cap
$235.3M
$32.3M
Price % of 52-Week High
36.2%
46.89%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.66%
1-Year Price Total Return
-58.27%
-37.62%
Beta (5-Year)
1.055
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $5.83
200-day SMA
Sell
Level $9.43
Bollinger Bands (100)
Sell
Level 5.16 - 8.14
Chaikin Money Flow
Sell
Level -7.6M
20-day SMA
Buy
Level $5.36
Relative Strength Index (RSI14)
Buy
Level 56.72
ADX Line
Buy
Level 14.31
Williams %R
Neutral
Level -43.822
50-day SMA
Buy
Level $5.38
MACD (12, 26)
Buy
Level 0.20
25-day Aroon Oscillator
Buy
Level 76
On Balance Volume
Neutral
Level 987.1K

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.4502)
Buy
CA Score (Annual)
Level (0.5366)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-1.1806)
Sell
Piotroski F Score (Annual)
Level (3)
Sell
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Stock Forecast FAQ

In the current month, QTRX has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The QTRX average analyst price target in the past 3 months is $11.25.

  • Where Will Quanterix Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Quanterix share price will rise to $11.25 per share over the next 12 months.

  • What Do Analysts Say About Quanterix?

    Analysts are divided on their view about Quanterix share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Quanterix is a Sell and believe this share price will drop from its current level to $7.00.

  • What Is Quanterix's Price Target?

    The price target for Quanterix over the next 1-year time period is forecast to be $11.25 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is QTRX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Quanterix is a Hold. 2 of 3 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of QTRX?

    You can purchase shares of Quanterix via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Quanterix shares.

  • What Is The Quanterix Share Price Today?

    Quanterix was last trading at $6.32 per share. This represents the most recent stock quote for Quanterix. Yesterday, Quanterix closed at $6.06 per share.

  • How To Buy Quanterix Stock Online?

    In order to purchase Quanterix stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will AST SpaceMobile Be In 5 Years?
Where Will AST SpaceMobile Be In 5 Years?

Ever tried to send a text from the Nevada desert…

Is TTD The Big Winner If Pharma Ads Are Banned?
Is TTD The Big Winner If Pharma Ads Are Banned?

Last week, Senators Bernie Sanders and Angus King introduced a…

Is Palantir Stock Overvalued?
Is Palantir Stock Overvalued?

By every traditional yardstick, including a price‑to‑sales well above 100,…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
11
VEON alert for Jun 16

VEON [VEON] is up 4.61% over the past day.

Buy
74
DAVE alert for Jun 16

Dave [DAVE] is up 3.92% over the past day.

Buy
54
DAR alert for Jun 16

Darling Ingredients [DAR] is up 7.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock